CASP4 expression tracks fibrosis severity in metabolic dysfunction-associated steatotic liver disease and CASP4-targeting siRNA reduces inflammatory hepatocyte injury
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) involves heterogeneous inflammatory and fibrotic states.